adapted Chicago Run running program for Arthrogryposis
Study Summary
This trial is testing a new program to help young people with disabilities stay fit, by providing accessible running programs at community locations.
- Arthrogryposis
- Myelomeningocele
- Gross Motor Development Delay
- Cerebral Palsy
- Motor Skills Disorders
Treatment Effectiveness
Effectiveness Progress
Study Objectives
4 Primary · 2 Secondary · Reporting Duration: at 8 weeks
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Running group
1 of 1
Experimental Treatment
25 Total Participants · 1 Treatment Group
Primary Treatment: adapted Chicago Run running program · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age < 65 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:About The Reviewer
Michael Gill - B. Sc.
First Published: October 30th, 2021
Last Reviewed: November 17th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.